BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Russo E, Giudici F, Ricci F, Scaringi S, Nannini G, Ficari F, Luceri C, Niccolai E, Baldi S, D'Ambrosio M, Ramazzotti M, Amedei A. Diving into Inflammation: A Pilot Study Exploring the Dynamics of the Immune-Microbiota Axis in Ileal Tissue Layers of Patients with Crohn's Disease. J Crohns Colitis 2021;15:1500-16. [PMID: 33611347 DOI: 10.1093/ecco-jcc/jjab034] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Cacciotto C, Alberti A. Eating the Enemy: Mycoplasma Strategies to Evade Neutrophil Extracellular Traps (NETs) Promoting Bacterial Nucleotides Uptake and Inflammatory Damage. IJMS 2022;23:15030. [DOI: 10.3390/ijms232315030] [Reference Citation Analysis]
2 Zhang X, Zhao X, Hua Z, Xing S, Li J, Fei S, Tan M. ROS-triggered self-disintegrating and pH-responsive astaxanthin nanoparticles for regulating the intestinal barrier and colitis. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121937] [Reference Citation Analysis]
3 Fiorindi C, Russo E, Balocchini L, Amedei A, Giudici F. Inflammatory Bowel Disease and Customized Nutritional Intervention Focusing on Gut Microbiome Balance. Nutrients 2022;14:4117. [PMID: 36235770 DOI: 10.3390/nu14194117] [Reference Citation Analysis]
4 Fiorentini E, Russo E, Amedei A, Bellando Randone S. Fecal microbiome in systemic sclerosis, in search for the best candidate for microbiota-targeted therapy for small intestinal bacterial overgrowth control. Journal of Scleroderma and Related Disorders 2022;7:163-7. [DOI: 10.1177/23971983221118871] [Reference Citation Analysis]
5 Federica R, Edda R, Daniela R, Simone B, Giulia N, Gabriele L, Marta M, Marco P, Gianluca B, Elena N, Matteo C, Serena S, Matteo R, Amedeo A, Salvatore CA. Characterization of the “gut microbiota-immunity axis” and microbial lipid metabolites in atrophic and potential celiac disease. Front Microbiol 2022;13:886008. [DOI: 10.3389/fmicb.2022.886008] [Reference Citation Analysis]
6 Bartolini I, Nannini G, Risaliti M, Matarazzo F, Moraldi L, Ringressi MN, Taddei A, Amedei A. Impact of microbiota-immunity axis in pancreatic cancer management. World J Gastroenterol 2022; 28(32): 4527-4539 [DOI: 10.3748/wjg.v28.i32.4527] [Reference Citation Analysis]
7 Fan Y, Su Q, Chen J, Wang Y, He S. Gut Microbiome Alterations Affect Glioma Development and Foxp3 Expression in Tumor Microenvironment in Mice. Front Oncol 2022;12:836953. [PMID: 35345443 DOI: 10.3389/fonc.2022.836953] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
8 Russo E, Nannini G, Sterrantino G, Kiros ST, Di Pilato V, Coppi M, Baldi S, Niccolai E, Ricci F, Ramazzotti M, Pallecchi M, Lagi F, Rossolini GM, Bartoloni A, Bartolucci G, Amedei A. Effects of viremia and CD4 recovery on gut “microbiome-immunity” axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy. World J Gastroenterol 2022; 28(6): 635-652 [PMID: 35317423 DOI: 10.3748/wjg.v28.i6.635] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Amedei A, Capasso C, Nannini G, Supuran CT. Microbiota, Bacterial Carbonic Anhydrases, and Modulators of Their Activity: Links to Human Diseases? Mediators Inflamm 2021;2021:6926082. [PMID: 34803517 DOI: 10.1155/2021/6926082] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
10 Islam SMS, Ryu HM, Sayeed HM, Byun HO, Jung JY, Kim HA, Suh CH, Sohn S. Eubacterium rectale Attenuates HSV-1 Induced Systemic Inflammation in Mice by Inhibiting CD83. Front Immunol 2021;12:712312. [PMID: 34531862 DOI: 10.3389/fimmu.2021.712312] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]